Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 The post invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m appeared first on Pharmaceutical Technology.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

Pharmaceutical Technology

MARCH 1, 2023

Sunshine Biopharma has signed an exclusive global licence deal with the University of Arizona for PLpro-based Covid-19 treatment. Since February last year, Sunshine Biopharma has been working along with the University of Arizona on this project. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.

Biopharma 59

Biopharma Food and Drug Administration Pharmacology Food 59

pharmaphorum

AUGUST 11, 2022

As the space regroups, join the likes of Compugen , iTeos Therapeutics , Genentech , Mereo BioPharma , Gilead Sciences , Nectin Therapeutics , Shattuck Lab s, Graphite Bio , GlaxoSmithKline and many more to build meaningful partnerships and maximize the clinical and commercial success of the next generation of TIGIT axis targeted drugs.

Pharmacology 57

Pharmacology Biopharma Pharma 57

European Pharmaceutical Review

OCTOBER 27, 2022

The report’s authors identified that nearly 36 percent of biopharma companies will be increasing their spending on outsourced R&D or biomanufacturing over the next 12 months. Average budgets for outsourcing at individual facilities also remain relatively steady, growing by a weighted average increase of 12.8 percent in 2022.

Biopharma 83

Biopharma Manufacturing Pharmacology Training 83

Pharmaceutical Technology

MAY 15, 2023

As molecular targeting peptides, anti-cancer peptides penetrate the plasma membrane, nuclear membrane, and mitochondrial membrane of cancer cells, exerting pharmacological activity through various mechanisms (such as inhibiting DNA synthesis and cell division), thus causing apoptosis of cancer cells.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 24, 2023

Several tetrapeptides are pharmacologically active, showing affinity and specificity for multiple receptors in protein-protein signalling. Whilst Abliva and Ambrx Biopharma stand in second and third positions, respectively. Merck 42 Unlock company profile C. Menarini Industrie Farmaceutiche Riunite.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Pharmacology 52

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Pharmacology Government Healthcare 111